Authors: D'Andrea, G Fennelly, D Norton, L Baselga, J Gilewski, T Hudis, C Moynahan, ME Raptis, G Sklarin, N Surbone, A Theodoulou, M Templeton, MA Yao, TJ Seidman, AD

Citation: G. D'Andrea et al., Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer, CLIN CANC R, 5(2), 1999, pp. 275-279

Authors: Hudis, C Seidman, A Baselga, J Raptis, G Lebwohl, D Gilewski, T Moynahan, M Sklarin, N Fennelly, D Crown, JPA Surbone, A Uhlenhopp, M Riedel, E Yao, TJ Norton, L

Citation: C. Hudis et al., Sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide for resectable high-risk breast cancer: Feasibility and efficacy, J CL ONCOL, 17(1), 1999, pp. 93-100

Authors: Husain, A Sabbatini, P Spriggs, D Fennelly, D Aghajanian, C Barakat, R Curtin, J Venkatraman, E Hoskins, W Markman, M

Citation: A. Husain et al., Phase II trial of intraperitoneal cisplatin and mitoxantrone in patients with persistent ovarian cancer, GYNECOL ONC, 73(1), 1999, pp. 96-101